Susquehanna International »

X4 Pharmaceuticals shares owned by Susquehanna International

Quarter-by-quarter ownership of X4 Pharmaceuticals (XFOR) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in X4 Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including X4 Pharmaceuticals held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in X4 Pharmaceuticals by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $437k 128k 3.42
2025-06-30 $309k 163k 1.90

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding X4 Pharmaceuticals

Bain Capital Life Sciences Investors
BVF
Nantahala Capital Management
Rosalind Advisors
Deep Track Capital
Stonepine Capital Management
Kingdon Capital Management
Stempoint Capital
Vanguard Group
Boothbay Fund Management
Pale Fire Capital SE
UBS Group
Susquehanna International
Palumbo Wealth Management
Geode Capital Management

View all funds holding X4 Pharmaceuticals